Mirion Technologies, Inc. Reiterates Revenue Guidance for the Twelve Month Period Ending December 31, 2023
November 01, 2023 at 04:30 pm EDT
Share
Mirion Technologies, Inc. reiterates revenue guidance for the twelve month period ending December 31, 2023. The company expects Revenue growth of 8% - 10% and Organic revenue growth of 6% - 8%.
Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets. The Company's segments include Medical and Technologies. The Medical segment includes products and services for radiation therapy and personal dosimetry. This segment's offerings include solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy; solutions for monitoring the total amount of radiation medical staff members are exposed to over time, and products for nuclear medicine in radiation measurement, shielding, product handling, medical imaging furniture and rehabilitation. The Technologies segment includes products and services for defense, nuclear energy, laboratories and research and other industrial markets. This segment's offerings include reactor safety and control systems, and radiological search, measurement and analysis systems.
MIRION TECHNOLOGIES, INC. 
